Damage extent and predictors in adult and juvenile dermatomyositis and polymyositis as determined with the myositis damage index
Open Access
- 29 October 2009
- journal article
- research article
- Published by Wiley in Arthritis & Rheumatism
- Vol. 60 (11), 3425-3435
- https://doi.org/10.1002/art.24904
Abstract
Objective We undertook this study to validate the Myositis Damage Index (MDI) in juvenile and adult myositis, to describe the degree and types of damage and to develop predictors of damage. Methods Retrospective MDI evaluations and prospective assessment of disease activity and illness features were conducted. Patients with juvenile‐onset disease (n = 143) were evaluated a median of 18 months after diagnosis; 135 patients were assessed 7–9 months later, and 121 were last assessed a median of 82 months after diagnosis. Ninety‐six patients with adult‐onset dermatomyositis or polymyositis had a baseline assessment a median of 30 months after diagnosis; 77 patients had a 6‐month followup evaluation, and 55 had a final assessment a median of 60 months after diagnosis. Results Damage was present in 79% of juvenile patients and in 97% of adult patients. In juveniles, scarring, contractures, persistent weakness, muscle dysfunction, and calcinosis were most frequent (23–30%) at the last evaluation. In adults, muscle atrophy, muscle dysfunction, and muscle weakness were most frequent (74–84%). MDI severity correlated with physician‐assessed global damage, serum creatinine, and muscle atrophy on magnetic resonance imaging, and in juveniles also with functional disability and weakness. MDI damage scores and frequency were highest in patients with a chronic illness course and in adult patients who died. Predictors of damage included functional disability, duration of active disease, disease severity at diagnosis, physician‐assessed global disease activity, and illness features, including ulcerations in children and pericarditis in adults. Conclusion Damage is common in myositis after a median duration of 5 years in patients with adult‐onset disease and 6.8 years in patients with juvenile‐onset disease. The MDI has good content, construct, and predictive validity in juvenile and adult myositis.Keywords
This publication has 36 references indexed in Scilit:
- Distribution and severity of weakness among patients with polymyositis, dermatomyositis and juvenile dermatomyositisRheumatology, 2008
- Influence of gender and age of onset on the outcome in children with systemic lupus erythematosusClinical Rheumatology, 2008
- Predictors of Acquired Lipodystrophy in Juvenile-Onset Dermatomyositis and a Gradient of SeverityMedicine, 2008
- Difference in disease features between childhood‐onset and adult‐onset systemic lupus erythematosusArthritis & Rheumatism, 2008
- Accrual of organ damage over time in Argentine patients with systemic lupus erythematosus: a multi-centre studyClinical Rheumatology, 2007
- Is antibody clustering predictive of clinical subsets and damage in systemic lupus erythematosus?Arthritis & Rheumatism, 2005
- Long-Term Survival of Patients With Idiopathic Inflammatory Myopathies According to Clinical FeaturesMedicine, 2004
- Systemic lupus erythematosus in three ethnic groups. XX. Damage as a predictor of further damageRheumatology, 2003
- Development of validated disease activity and damage indices for the juvenile idiopathic inflammatory myopathies. I. Physician, parent, and patient global assessmentsArthritis & Rheumatism, 1997
- The development and initial validation of the systemic lupus international collaborating clinics/American college of rheumatology damage index for systemic lupus erythematosusArthritis & Rheumatism, 1996